FisherVista

Greenland Mines Ltd. is advancing a diversified critical minerals strategy in Greenland, targeting resources essential for EVs, renewable energy, and defense, as governments seek supply chain security.

Quantum BioPharma receives FDA approval to advance its first-in-class MS drug Lucid-MS into Phase 2 trials, marking a significant step toward a potential neuroprotective therapy for multiple sclerosis.

Forward Industries expanded its Solana holdings by over 500,000 SOL in fiscal Q3 2026, achieving 36% annualized SOL-per-share growth and gaining access to institutional capital via Russell index inclusion.

PX1 Research launches domestically manufactured sublingual peptide strips for needle-free research, offering a non-invasive alternative to injectable compounds with verified purity.

Investors often confuse paper losses on K-1 forms with actual financial losses, but in multifamily real estate, these losses signal valuable tax benefits that can shelter income and carry forward indefinitely.

The largest gathering of electric aircraft at Oshkosh AirVenture shows that the electric aviation revolution is broader than flying cars, encompassing converted traditional aircraft and high-volume manufacturing plans.

PX1 Research now applies cGMP quality control and seven-stage HPLC purity verification to all US-manufactured research peptides, ensuring 99%+ purity with batch-specific documentation.

EquiDeFi Prometheus AI SPV opens a private offering for accredited investors to gain indirect exposure to Series B preferred shares of a major pre-IPO AI company, highlighting the growing trend of alternative investments in high-growth tech.

SKYX Platforms will host its Q2 2026 earnings call, providing critical updates on its smart home technologies and financial performance, impacting investors and the smart building industry.

As AI demand surges, the focus shifts to the physical infrastructure—power, data centers, and connectivity—with companies like AZIO AI Holdings positioning themselves to address the impending energy crisis.

As AI adoption accelerates, the demand for physical infrastructure like data centers and power is surging, with AZIO AI Holdings strategically positioning itself through major initiatives including a 500-megawatt Texas campus and NVIDIA system acquisition.

Nicola Mining and Ocean Partners have each invested $5 million in Blue Lagoon Resources to accelerate production at its Dome Mountain Gold and Silver Project in British Columbia.

NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a more practical treatment option in outbreak settings.

As AI adoption drives projected doubling of data-center electricity consumption by 2030, companies like AZIO AI Holdings are racing to build the power and infrastructure backbone, highlighting a critical investment shift.

Amid tightening copper concentrate supplies, Chinese smelters are switching to scrap metal, driving processing charges deeper into negative territory and potentially boosting revenues for by-product producers like Platinum Group Metals Ltd.

Hainan's strategic push into marine tourism and the ocean economy, highlighted by a 48.8% surge in inbound visits, showcases the Free Trade Port's policy-driven growth and ecological innovation.

Information Services Group's second-quarter results beat guidance, with AI-related revenue up 64% and record recurring revenue, indicating improved operating leverage and a robust pipeline for 2H26.

Lahontan Gold Corp. is progressing its Nevada gold and silver portfolio, highlighting the strategic importance of domestic precious metals production.

Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in TNBC models, supporting its planned Phase 1/2 clinical trial.

Aemetis Inc.'s second-quarter results reveal a clear operating inflection with positive operating income and adjusted EBITDA, driven by record RNG production and improved ethanol economics, despite a revenue miss tied to India tender timing.

Park-Ohio Holdings' second-quarter results reveal a clearer inflection in its portfolio, with record gross margins and raised guidance, suggesting the core business is improving faster than consolidated results imply.